Mammographic density changes during different postmenopausal hormone replacement therapies

Fertility and Sterility

Volumn 76, Issue 3, 2001, Pages 445-450

  Enda, Fatih ^a,b   Coşan Terek, Mustafa ^a   Özşener, Serdar ^a   Öztekin, Kemal ^a   Bilgin, Onur ^a   Bilgen, Işil ^a   Memiş, Ayşenur ^a  

^a Faculty of Medicine   (Turkey)

^b EGE UNIVERSITY   (Turkey)

Author keywords

Hormone replacement therapy; Mammographic breast density

Indexed keywords

CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; ESTRADIOL PLUS NORETHISTERONE ACETATE; ESTROGEN; GESTAGEN; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE ACETATE; TIBOLONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SCREENING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; ESTROGEN THERAPY; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAMMOGRAPHY; POSTMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT;

CYPROTERONE ACETATE; DRUG COMBINATIONS; ESTRADIOL; ESTRIOL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; MAMMOGRAPHY; MEDROXYPROGESTERONE 17-ACETATE; MIDDLE AGED; NORETHINDRONE; NORPREGNENES; POSTMENOPAUSE; PROGESTERONE CONGENERS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 0034893493     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(01)01935-5     Document Type: Article

References (26)

1. Breast cancer and hormone replacement therapy; collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer
2. Breast cancer screening with mammography; overview of Swedish randomized trials
3. The mammographic density in women on postmenopausal hormone replacement therapy
4. Mammographic density in women on postmenopausal hormone replacement therapy
5. Effect of estrogen and estrogen-progestin replacement regimens on mammographic breast parechymal density
6. Mammographic and ultrasonographic study of changes in the breast related to HRT
7. Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern
8. Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography
9. Breast patterns as an index of risk for developing breast cancer
10. Risk for breast cancer development determined by mammographic parenchymal pattern
11. Mammographic density changes in perimenopausal and postmenopausal women; is effect of hormone replacement therapy predictable?
12. Proliferation of breast epithelial cells in healthy women during the menstrual cycle
13. Effects of hormone replacement therapy on the mammary gland of surgically postmenopausal cynomolgus macaques
14. Endocrine and paracrine hormones in the promotion, progression and recurrence of breast cancer
15. The role of progestins and antiprogestins in the treatment of breast cancer
16. Steroid hormones and cancer. II. Lessons from experimental systems
17. Estrogens, progestogens, normal berat cell proliferation, and breast cancer risk
18. Mammographic breast density during hormone replacement therapy; differences according to treatment
19. Mammographic changes associated with postmenopausal hormone replacement therapy; a longitudinal study
20. Hormonal replacement therapy; mammographic manifestations
21. Mammographic changes in postmenopausal women on hormonal replacement therapy
22. Progestin regulation of cellular proliferation
23. A correlative morphologic study of human breast and endothelium in the menstrual cycle
24. Effect of tibolone (Org OD14) and its metabolites on estrone sulphatase activity in MCF-7 and T-47D mammary cancer cells
25. Mammographic changes in women receiving tibolone therapy